Gastric Ulcer: Clinical Trials

61 trials for Gastric Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 10 unknown, 5 recruiting, 3 terminated. 24 Phase 3, 10 Not applicable, 7 Phase 1, 6 Phase 4, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 324Completed 20, Unknown 2, Not yet recruiting 1, Terminated 1
Not applicable10Unknown 6, Completed 3, Recruiting 1
Phase 17Completed 6, Recruiting 1
Phase 46Completed 4, Not yet recruiting 1, Unknown 1
Phase 23Completed 2, Unknown 1

Follow Gastric Ulcer: new trials by email Literature Review of Gastric Ulcer trials Research Report on Gastric Ulcer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer
DWP14012 40mg (Fexuprazan), Lansoprazole 30mg - Gastric Ulcer
Phase 3Not yet recruitingDaewoong Pharmaceutical Co. LTD.3842026-10-152026-07-28
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
Esomeprazole (Intravenous), Esomeprazole (Oral), Sucralfate Suspension - Early Gastric Cancer, Gastric Dysplasia
Phase 4Not yet recruitingLanZhou University1202026-04-202026-03-23
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
AD-115A, AD-1151 - Gastric Ulcer
Phase 1RecruitingAddpharma Inc.462026-01-272026-02-11
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Collect epidemiological, diagnostic, and follow-up data after MCG examination. - Gastritis, Gastric Dysplasia
RecruitingNanfang Hospital, Southern Medical University100002025-06-242025-07-04
The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
AD-115A, AD-1151 - Gastric Ulcer
Phase 1CompletedAddpharma Inc.462025-03-212025-10-03
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
AI-integrated Capsule Gastroscopy (ACG) examination, Electronic gastroduodenoscopy (EGD) examination - Gastric Lesion, Gastritis
Not applicableRecruitingNanfang Hospital, Southern Medical University4822025-03-032025-07-09
Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.
Vonoprazan Test 20mg, Vonoprazan Reference 20mg - Gastric Ulcer
Phase 1CompletedHanlim Pharm. Co., Ltd.302023-10-232024-10-16
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
HIP0612, HPP2202, RLD2204 - Gastric Ulcer
Phase 3CompletedHanmi Pharmaceutical Company Limited1992023-03-062025-02-19
Systems Biology of Gastrointestinal and Related Diseases
Ulcerative Colitis, Crohn Disease
TerminatedViome172022-11-112023-12-15
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
JP-1366 20mg, Lansoprazole 30mg - Gastric Ulcer
Phase 3CompletedOnconic Therapeutics Inc.3292022-09-192024-08-26
Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.
ciprofol - Gastric Cancer, Gastric Ulcer
Not applicableUnknownRenJi Hospital302022-09-192023-08-16
Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients
Ciprofol, Propofol - Gastric Ulcer, Gastric Cancer
Phase 4CompletedRenJi Hospital10902022-09-082024-06-07
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
No Interventions - Cancer Diagnosis, Liver Cancer, Adult
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine6002022-09-012025-04-24
HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients
High-flow nasal oxygenation combined with nasopharyngeal airway, Regular nasal cannula combined with nasopharyngeal airway - Gastric Cancer, Gastric Ulcer
Not applicableUnknownRenJi Hospital6002022-09-012022-09-02
Understanding Ayurveda Disease Conditions and Treatment Responses
Personalized Ayurveda treatment protocol - Type2diabetes, Rheumatoid Arthritis
CompletedAyurai Private Limited4972021-12-292023-12-21
Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy
Eupatilin, Rebamipide - Rheumatoid Arthritis, Osteoarthritis
Phase 4UnknownSeoul National University Boramae Hospital502021-06-012021-05-13
MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)
MAGNET - Abdominal Pain, Gastritis
Not applicableCompletedGeorge Washington University432021-02-102023-09-11
Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
No intervention will be given to patients. - Colorectal Cancer, Gastric Cancer
RecruitingRenmin Hospital of Wuhan University10002020-12-232022-04-29
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
Berberine, Amoxicillin, Esomeprazole - Gastric Ulcer, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases6582018-08-012019-08-30
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
D961H capsule 10mg, D961H sachet 10mg - Reflux Esophagitis, Gastric Ulcer
Phase 3CompletedAstraZeneca502018-07-242026-03-04

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Stomach Ulcer (61)  ·  Duodenal Ulcer (22)  ·  Stomach Neoplasms (14)  ·  Gastritis (10)  ·  Arthritis, Rheumatoid (5)  ·  Osteoarthritis (4)  ·  Abdominal Pain (3)  ·  Gastroesophageal Reflux (3)  ·  Peptic Ulcer (3)  ·  Anorexia (2)  ·  Colorectal Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Esophagitis, Peptic (2)  ·  Gastrointestinal Diseases (2)  ·  Helicobacter Infections (2)

Broader conditions

Digestive System Diseases (61)  ·  Duodenal Diseases (61)  ·  Intestinal Diseases (61)  ·  Stomach Diseases (61)  ·  Gastrointestinal Diseases (59)  ·  Peptic Ulcer (58)  ·  Gastroenteritis (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Digestive System Neoplasms (14)  ·  Gastrointestinal Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Neoplasms (13)  ·  Signs and Symptoms (9)  ·  Esophageal Diseases (6)  ·  Immune System Diseases (6)

Interventions

Esomeprazole (9)  ·  Lansoprazole (6)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (4)  ·  Naproxen (4)  ·  Amoxicillin (3)  ·  (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (2)  ·  Clarithromycin (2)  ·  Rabeprazole (2)  ·  rebamipide (2)  ·  2-(6-methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl ester (1)  ·  Aftercare (1)  ·  Arthotec (1)  ·  Arthrotec (1)  ·  Berberine (1)  ·  Bismuth (1)

Sponsors

AstraZeneca (10)  ·  POZEN (6)  ·  Hamamatsu University (4)  ·  Takeda (4)  ·  Nanfang Hospital, Southern Medical University (3)  ·  RenJi Hospital (3)  ·  Addpharma Inc. (2)  ·  DiaSorin Inc. (2)  ·  Eisai Co., Ltd. (2)  ·  Antibe Therapeutics Inc. (1)  ·  Ayurai Private Limited (1)  ·  Boryung Pharmaceutical Co., Ltd (1)  ·  Chinese University of Hong Kong (1)  ·  Daewoong Pharmaceutical Co. LTD. (1)  ·  First Affiliated Hospital of Zhejiang University (1)

Countries

Japan (15)  ·  China (14)  ·  South Korea (12)  ·  United States (11)  ·  Italy (4)  ·  Taiwan (3)  ·  Canada (2)  ·  Hong Kong (2)  ·  Indonesia (2)  ·  Philippines (2)  ·  Argentina (1)  ·  Australia (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Finland (1)

Top investigators

Everardus Orlemans, PhD (4)  ·  Shigeru Yoshida, MD (3)  ·  Diansan Su (2)  ·  Naotsugu Oyama (2)  ·  Andrew C Meltzer, MD, MS (1)  ·  Angelo Zullo, MD (1)  ·  Anita Kumar, MD (1)  ·  David Cave, MD (1)  ·  Deepen Patel, MD (1)  ·  Dr. Laeeque Ahmed, Asst. Professor (1)  ·  Francis K Chan, MD (1)  ·  James Scheiman, MD (1)  ·  Jyh-Chin Yang, M.D. (1)  ·  Katsuya Sugizaki (1)

Results publications

PMID 12641522, PMID 20230209, PMID 21319944, PMID 21415072, PMID 21726257, PMID 22591121, PMID 23188121, PMID 23530709, PMID 24714327, PMID 27397702, PMID 27891632, PMID 31483889, PMID 32348007, PMID 34197702, PMID 36342574, PMID 38238541, PMID 38424039, PMID 39085080, PMID 41540828, PMID 41626789

NIH funding

2018 (1)